Riskpilot← Back to searchSign inGet full accessExuberantus AB
ABActiveOrg 5591277180Hagaborgsvägen 1General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 12K
-79% vs 2023
EBITDA margin
66.7%
-84% vs 2023
Equity ratio
89.7%
Financial strength
Net profit 2024
SEK 7K
-82% vs 2023
| Revenue | SEK 12K | -79% |
| EBITDA | SEK 8K | -84% |
| Net profit | SEK 7K | -82% |
| Total assets | SEK 68K | -38% |
| Equity | SEK 61K | -35% |
| Employees | 0 | — |
Legal name
Exuberantus AB
Org number
5591277180
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 oktober 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet gentemot vårdcentraler och sjukhus för att bemanna med läkartjänster där det behövs. Bolaget kan också komma att bedriva konsultverksamhet inom e- hälsa. Bolaget kan också bedriva handel med värdepapper.
Address
Hagaborgsvägen 1
Email
eric_danielsson@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 81 | 74 | 118 | 138 | 158 | 58 | 12 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 65 | 53 | 91 | 130 | 134 | 49 | 8 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 65 | 53 | 91 | 130 | 134 | 49 | 8 |
| Net financials | — | — | — | — | — | — | 1 |
| Profit before tax | 64 | 53 | 91 | 130 | 134 | 49 | 9 |
| Tax | −14 | −11 | −20 | −27 | −29 | −11 | −2 |
| Net profit | 50 | 42 | 71 | 103 | 105 | 38 | 7 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 115 | 139 | 174 | 218 | 222 | 110 | 68 |
| Equity | 100 | 92 | 123 | 153 | 155 | 94 | 61 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 14 | 47 | 52 | 65 | 66 | 16 | 7 |
| Total debt | 14 | 47 | 52 | 65 | 66 | 16 | 7 |
EBITDA margin
66.7%
This company
15.8%
Market median
+322% vs market
20182024
Equity ratio
89.7%
This company
38.2%
Market median
+135% vs market
20182024
Return on equity
11.5%
This company
18.4%
Market median
+37% vs market
20182024
Net profit margin
58.3%
This company
8.1%
Market median
+620% vs market
20182024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20182024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20182024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-10-01 – 2018-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Exuberantus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofia Maria Hofsöe | Deputy Board Member | 0 companies |
| Eric William Danielsson | Board of Directors | 0 companies |